Learning Objectives:

 

1.  Identify reasons for the failure of GLP-1 analogues in obesity management, focusing on adherence, pharmacological resistance, and individual metabolic differences.

2.  Compare alternative pharmacological and non-pharmacological strategies for patients who do not respond to GLP-1 analogues.

3.  Create holistic management plans that combine behavioral, dietary, exercise, and psychological interventions with other treatments for complex obesity cases.

Session date: 
09/19/2024 - 7:00am to 8:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Alisha Wilson, MSN, APRN, FNP-C, CBN